The U.S. Vaccine Adjuvants Market is projected to grow from USD 0.62 Billion in 2025 to USD 1.61 Billion by 2035, while ...
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results